Literature DB >> 28147276

Mesenchymal Stem Cell-Induced DDR2 Mediates Stromal-Breast Cancer Interactions and Metastasis Growth.

Maria E Gonzalez1, Emily E Martin1, Talha Anwar1, Caroline Arellano-Garcia1, Natasha Medhora1, Arjun Lama1, Yu-Chih Chen2, Kevin S Tanager1, Euisik Yoon3, Kelley M Kidwell4, Chunxi Ge5, Renny T Franceschi5, Celina G Kleer6.   

Abstract

Increased collagen deposition by breast cancer (BC)-associated mesenchymal stem/multipotent stromal cells (MSC) promotes metastasis, but the mechanisms are unknown. Here, we report that the collagen receptor discoidin domain receptor 2 (DDR2) is essential for stromal-BC communication. In human BC metastasis, DDR2 is concordantly upregulated in metastatic cancer and multipotent mesenchymal stromal cells. In MSCs isolated from human BC metastasis, DDR2 maintains a fibroblastic phenotype with collagen deposition and induces pathological activation of DDR2 signaling in BC cells. Loss of DDR2 in MSCs impairs their ability to promote DDR2 phosphorylation in BC cells, as well as BC cell alignment, migration, and metastasis. Female ddr2-deficient mice homozygous for the slie mutation show inefficient spontaneous BC metastasis. These results point to a role for mesenchymal stem cell DDR2 in metastasis and suggest a therapeutic approach for metastatic BC.
Copyright © 2017 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DDR2; EZH2; breast cancer; collagen; discoidin domain receptor; mesenchymal stem cell; metastasis; microenvironment; phosphorylated DDR2; tumor stroma

Mesh:

Substances:

Year:  2017        PMID: 28147276      PMCID: PMC5332146          DOI: 10.1016/j.celrep.2016.12.079

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  42 in total

Review 1.  Discoidin domain receptor tyrosine kinases: new players in cancer progression.

Authors:  Rajeshwari R Valiathan; Marta Marco; Birgit Leitinger; Celina G Kleer; Rafael Fridman
Journal:  Cancer Metastasis Rev       Date:  2012-06       Impact factor: 9.264

2.  Human ovarian carcinoma–associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production.

Authors:  Karen McLean; Yusong Gong; Yunjung Choi; Ning Deng; Kun Yang; Shoumei Bai; Lourdes Cabrera; Evan Keller; Laurie McCauley; Kathleen R Cho; Ronald J Buckanovich
Journal:  J Clin Invest       Date:  2011-08       Impact factor: 14.808

3.  Discoidin domain receptor 2 interacts with Src and Shc following its activation by type I collagen.

Authors:  Kazuo Ikeda; Li-Hsien Wang; Richard Torres; Hong Zhao; Elvira Olaso; Francis J Eng; Pablo Labrador; Rudiger Klein; David Lovett; George D Yancopoulos; Scott L Friedman; Hsin Chieh Lin
Journal:  J Biol Chem       Date:  2002-03-07       Impact factor: 5.157

4.  Downregulation of discoidin domain receptor 2 in A375 human melanoma cells reduces its experimental liver metastasis ability.

Authors:  Iker Badiola; Patricia Villacé; Iratxe Basaldua; Elvira Olaso
Journal:  Oncol Rep       Date:  2011-06-23       Impact factor: 3.906

5.  Discoidin domain receptor 2 regulates fibroblast proliferation and migration through the extracellular matrix in association with transcriptional activation of matrix metalloproteinase-2.

Authors:  Elvira Olaso; Juan-Pablo Labrador; LiHsien Wang; Kazuo Ikeda; Francis J Eng; Rudiger Klein; David H Lovett; Hsin Chieh Lin; Scott L Friedman
Journal:  J Biol Chem       Date:  2001-11-26       Impact factor: 5.157

6.  Isolation and comparison of mesenchymal stem cell‑like cells derived from human gastric cancer tissues and corresponding ovarian metastases.

Authors:  Kunyan Zhou; Man Xia; Bo Tang; Darong Yang; Nianli Liu; Dihong Tang; Hailong Xie; Xiaohong Wang; Haizhen Zhu; Chen Liu; Chaohui Zuo
Journal:  Mol Med Rep       Date:  2015-12-30       Impact factor: 2.952

Review 7.  Role of discoidin domain receptor 2 in wound healing.

Authors:  Joana Márquez; Elvira Olaso
Journal:  Histol Histopathol       Date:  2014-04-29       Impact factor: 2.303

8.  CD24+ Ovarian Cancer Cells Are Enriched for Cancer-Initiating Cells and Dependent on JAK2 Signaling for Growth and Metastasis.

Authors:  Daniela Burgos-Ojeda; Rong Wu; Karen McLean; Yu-Chih Chen; Moshe Talpaz; Euisik Yoon; Kathleen R Cho; Ronald J Buckanovich
Journal:  Mol Cancer Ther       Date:  2015-05-12       Impact factor: 6.261

9.  Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling.

Authors:  Hua-Jung Li; Ferenc Reinhardt; Harvey R Herschman; Robert A Weinberg
Journal:  Cancer Discov       Date:  2012-07-03       Impact factor: 39.397

Review 10.  The evolution of the cancer niche during multistage carcinogenesis.

Authors:  Mary Helen Barcellos-Hoff; David Lyden; Timothy C Wang
Journal:  Nat Rev Cancer       Date:  2013-06-13       Impact factor: 69.800

View more
  34 in total

1.  Induction of ALP and MMP9 activity facilitates invasive behavior in heterogeneous human BMSC and HNSCC 3D spheroids.

Authors:  Anja Wessely; Anna Waltera; Torsten E Reichert; Sabine Stöckl; Susanne Grässel; Richard J Bauer
Journal:  FASEB J       Date:  2019-07-31       Impact factor: 5.191

2.  A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer.

Authors:  Sabra I Djomehri; Boris Burman; Maria E Gonzalez; Shuichi Takayama; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-12-04       Impact factor: 5.782

Review 3.  The interplay between extracellular matrix remodelling and kinase signalling in cancer progression and metastasis.

Authors:  Joanna N Skhinas; Thomas R Cox
Journal:  Cell Adh Migr       Date:  2017-12-29       Impact factor: 3.405

4.  Tumor microenvironment heterogeneity: challenges and opportunities.

Authors:  F Runa; S Hamalian; K Meade; P Shisgal; P C Gray; J A Kelber
Journal:  Curr Mol Biol Rep       Date:  2017-10-30

5.  Heat shock protein 47 (HSP47) binds to discoidin domain-containing receptor 2 (DDR2) and regulates its protein stability.

Authors:  Jie Chen; Shike Wang; Zhihui Zhang; Christopher I Richards; Ren Xu
Journal:  J Biol Chem       Date:  2019-09-30       Impact factor: 5.157

6.  DDR2 upregulation confers ferroptosis susceptibility of recurrent breast tumors through the Hippo pathway.

Authors:  Chao-Chieh Lin; Wen-Hsuan Yang; Yi-Tzu Lin; Xiaohu Tang; Po-Han Chen; Chien-Kuang Cornelia Ding; Dan Chen Qu; James V Alvarez; Jen-Tsan Chi
Journal:  Oncogene       Date:  2021-02-18       Impact factor: 9.867

Review 7.  The matrix in cancer.

Authors:  Thomas R Cox
Journal:  Nat Rev Cancer       Date:  2021-02-15       Impact factor: 60.716

Review 8.  Complex roles of discoidin domain receptor tyrosine kinases in cancer.

Authors:  V Mehta; H Chander; A Munshi
Journal:  Clin Transl Oncol       Date:  2021-02-25       Impact factor: 3.405

Review 9.  Mesenchymal stem cells: From regeneration to cancer.

Authors:  Peishan Li; Zheng Gong; Leonard D Shultz; Guangwen Ren
Journal:  Pharmacol Ther       Date:  2019-04-16       Impact factor: 12.310

10.  Mesenchymal Stem/Stromal Cell Engulfment Reveals Metastatic Advantage in Breast Cancer.

Authors:  Yu-Chih Chen; Maria E Gonzalez; Boris Burman; Xintao Zhao; Talha Anwar; Mai Tran; Natasha Medhora; Ayse B Hiziroglu; Woncheol Lee; Yu-Heng Cheng; Yehyun Choi; Euisik Yoon; Celina G Kleer
Journal:  Cell Rep       Date:  2019-06-25       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.